Glatopa and Calcium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glatopa (glatiramer acetate) and Calcium (calcium). Common drug interactions include nausea among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Glatopa and Calcium. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Glatopa?

Glatopa has active ingredients of glatiramer acetate. eHealthMe is studying from 6,518 Glatopa users. Check the latest studies of Glatopa.

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. eHealthMe is studying from 184,203 Calcium users. Check the latest studies of Calcium.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

25 people who take Glatopa and Calcium together, and have interactions are studied.

Glatopa and Calcium drug interactions.

What are the common drug interactions of Glatopa and Calcium, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Injection site erythema (redness at injection site)
  3. Injection site pain
  4. Vomiting
  5. Dyspnoea (difficult or laboured respiration)
  6. Injection site haemorrhage (bleeding from injection site)
  7. Loss of consciousness
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Blood cholesterol increased
  10. Depression

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Chest discomfort
  3. Prostate cancer
  4. Dizziness
  5. Facial paralysis (loss of function of face muscle)
  6. Headache (pain in head)
  7. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  8. Hot flush (sudden feelings of heat)
  9. Hyperhidrosis (abnormally increased sweating)
  10. Hypoaesthesia (reduced sense of touch or sensation)

What are the common drug interactions of Glatopa and Calcium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dyspnoea (difficult or laboured respiration)
  2. Rash macular (small, flat red spots)
  3. Swelling face

30-39:

  1. Dyspnoea (difficult or laboured respiration)
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Blood alkaline phosphatase increased
  5. Blood bilirubin increased
  6. Constipation
  7. Facial paralysis (loss of function of face muscle)
  8. Fatigue (feeling of tiredness)
  9. Hot flush (sudden feelings of heat)
  10. Hyperhidrosis (abnormally increased sweating)

40-49:

n/a

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Injection site erythema (redness at injection site)
  3. Vomiting
  4. Injection site haemorrhage (bleeding from injection site)
  5. Loss of consciousness
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Chest discomfort
  8. Diarrhoea
  9. Dizziness
  10. Dyspnoea (difficult or laboured respiration)

60+:

  1. Injection site pain
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Throat irritation
  4. Weight increased
  5. Dizziness
  6. Ear infection
  7. Hypoacusis (loss of hearing)
  8. Injection related reaction
  9. Injection site bruising
  10. Injection site erythema (redness at injection site)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 20 people, 80.00%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 8.00%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Glatopa and Calcium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Glatopa and Calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glatopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glatopa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calcium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on glatiramer acetate and calcium (the active ingredients of Glatopa and Calcium, respectively), and Glatopa and Calcium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: